HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries.

Abstract
Although current value frameworks and economic models have allowed us to better quantify the net benefit associated with cancer therapy, holistic cancer care must consider patient time, family and social values, and overall life expectancy. Training programs must include training in health services research, difficult conversations, and shared decision-making strategies that are developed in social and cultural frameworks for their settings.
AuthorsMary Chamberlin, Christopher Booth, Gabriel A Brooks, Achille Manirakiza, Fidel Rubagumya, Verna Vanderpuye
JournalHematology/oncology clinics of North America (Hematol Oncol Clin North Am) Vol. 38 Issue 1 Pg. 229-238 (Feb 2024) ISSN: 1558-1977 [Electronic] United States
PMID37516631 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2023 Elsevier Inc. All rights reserved.
Topics
  • Humans
  • Developing Countries
  • Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: